ArticleScience advances2020

Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease.

Lenora Higginbotham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.